Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Versatis 5% patch for neuropathic pain and sickle cell vaso-occlusive pain in children, adolescents, and young adults
2010-023461-22Phase 2
- Sponsor
- Centre Léon Bérard
- Start
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of lidocaine in Neuralgia and sickle cell disease (SCD), sponsored by Centre Léon Bérard. Primary endpoint: Primary efficacy at 12 hours.
02
Drugs
lidocaine
03
Conditions
Neuralgiasickle cell disease (SCD)
Beyond the preview
Go deeper on 2010-023461-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023461-22.